Should HRT be duration limited?

Area of Science:

• Reproductive endocrinology and women's health.
• Menopause management and hormone therapy.

Background:

• Hormone Replacement Therapy (HRT) faces negative public perception and media portrayal.
• Concerns persist despite re-analyzed data and consensus statements supporting HRT.
• General Practitioners often limit HRT duration or discontinue it prematurely.

Purpose of the Study:

• To review current evidence on the safety and efficacy of HRT.
• To present new data on the long-term consequences of not treating Premature Ovarian Insufficiency (POI).
• To explore the implications of HRT for the older female workforce and propose management strategies.

Main Methods:

• Comprehensive review of existing and novel research on HRT safety.
• Analysis of long-term health outcomes in women with untreated POI.
• Exploration of workforce participation and health considerations for aging women.

Main Results:

• Re-evaluation of previous data and new studies indicate a more favorable safety profile for HRT than commonly perceived.
• Untreated POI is associated with significant long-term adverse health consequences.
• Evidence supports individualized HRT management plans.

Conclusions:

• A balanced, evidence-based approach to HRT is warranted, moving beyond outdated perceptions.
• Individualized HRT prescriptions should consider patient history, risks, and benefits.
• Addressing POI and supporting older women in the workforce requires informed HRT strategies.